Evaluating the Added Value of Synthetic Magnetic Resonance Imaging in Predicting Sentinel Lymph Node Status in Breast Cancer

Overview

Journal Quant Imaging Med Surg

Specialty Radiology

Date 2024 Jun 7

PMID 38846281

Authors

Xiao Yang

Zhou Lu

Xiaoying Tan

Lin Shao

Jie Shi

Weiqiang Dou

Zongqiong Sun

Affiliations

Soon will be listed here.

Abstract

Background: The noninvasive prediction of sentinel lymph node (SLN) metastasis using quantitative magnetic resonance imaging (MRI), particularly with synthetic MRI (syMRI), is an emerging field. This study aimed to explore the potential added benefits of syMRI over conventional MRI and diffusion-weighted imaging (DWI) in predicting metastases in SLNs.

Methods: This retrospective study consecutively enrolled 101 patients who were diagnosed with breast cancer (BC) and underwent SLN biopsy from December 2022 to October 2023 at the Affiliated Hospital of Jiangnan University. These patients underwent preoperative MRI including conventional MRI, DWI, and syMRI and were categorized into two groups according to the postoperative pathological results: those with and without metastatic SLNs. MRI morphological features, DWI, and syMRI-derived quantitative parameters of breast tumors were statistically compared between these two groups. Binary logistic regression was used to separately develop predictive models for determining the presence of SLN involvement, with variables that exhibited significant differences being incorporated. The performance of each model was evaluated through receiver operating characteristic (ROC) curve analysis, including the area under the curve (AUC), sensitivity, and specificity.

Results: Compared to the group of 54 patients with BC but no metastatic SLNs, the group of 47 patients with BC and metastatic SLNs had a significantly larger maximum axis diameter [metastatic SLNs: median 2.40 cm, interquartile range (IQR) 1.50-3.00 cm; no metastatic SLNs: median 1.80 cm, IQR 1.37-2.50 cm; P=0.03], a higher proton density (PD) (78.44±11.92 69.20±10.63 pu; P<0.001), and a lower apparent diffusion coefficient (ADC) (metastatic SLNs: median 0.91×10 mm/s, IQR 0.79-1.01 mm/s; no metastatic SLNs: median 1.02×10 mm/s, IQR 0.92-1.12 mm/s; P=0.001). Moreover, the prediction model with maximum axis diameter and ADC yielded an AUC of 0.71 [95% confidence interval (CI): 0.618-0.802], with a sensitivity of 78.72% and a specificity of 51.85%; After addition of syMRI-derived PD to the prediction model, the AUC increased significantly to 0.86 (AUC: 0.86 0.71; 95% CI: 0.778-0.922; P=0.002), with a sensitivity of 80.85% and a specificity of 81.50%.

Conclusions: Combined with conventional MRI and DWI, syMRI can offer additional value in enhancing the predictive performance of determining SLN status before surgery in patients with BC.

References

Warntjes J, Dahlqvist O, Lundberg P . Novel method for rapid, simultaneous T1, T2*, and proton density quantification. Magn Reson Med. 2007; 57(3):528-37. DOI: 10.1002/mrm.21165. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Cheang M, Chia S, Voduc D, Gao D, Leung S, Snider J . Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst. 2009; 101(10):736-50. PMC: 2684553. DOI: 10.1093/jnci/djp082. View

Barrio A, Montagna G, Mamtani A, Sevilimedu V, Edelweiss M, Capko D . Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy-A Rare Event. JAMA Oncol. 2021; 7(12):1851-1855. PMC: 8498932. DOI: 10.1001/jamaoncol.2021.4394. View

Li Q, Xiao Q, Yang M, Chai Q, Huang Y, Wu P . Histogram analysis of quantitative parameters from synthetic MRI: Correlations with prognostic factors and molecular subtypes in invasive ductal breast cancer. Eur J Radiol. 2021; 139:109697. DOI: 10.1016/j.ejrad.2021.109697. View

Ge Y, Hu S, Wang Z, Guan R, Zhou X, Gao Q . Feasibility and reproducibility of T2 mapping and DWI for identifying malignant lymph nodes in rectal cancer. Eur Radiol. 2020; 31(5):3347-3354. DOI: 10.1007/s00330-020-07359-7. View

Wang P, Hu S, Wang X, Ge Y, Zhao J, Qiao H . Synthetic MRI in differentiating benign from metastatic retropharyngeal lymph node: combination with diffusion-weighted imaging. Eur Radiol. 2022; 33(1):152-161. DOI: 10.1007/s00330-022-09027-4. View

Zhu Y, Jia Y, Pang W, Duan Y, Chen K, Nie F . Ultrasound contrast-enhanced patterns of sentinel lymph nodes: predictive value for nodal status and metastatic burden in early breast cancer. Quant Imaging Med Surg. 2023; 13(1):160-170. PMC: 9816714. DOI: 10.21037/qims-22-234. View

Gao W, Zhang S, Guo J, Wei X, Li X, Diao Y . Investigation of Synthetic Relaxometry and Diffusion Measures in the Differentiation of Benign and Malignant Breast Lesions as Compared to BI-RADS. J Magn Reson Imaging. 2020; 53(4):1118-1127. DOI: 10.1002/jmri.27435. View

10.

Bansal C, Pujani M, Sharma K, Srivastava A, Singh U . Grading systems in the cytological diagnosis of breast cancer: a review. J Cancer Res Ther. 2015; 10(4):839-45. DOI: 10.4103/0973-1482.140979. View

11.

Cai Q, Wen Z, Huang Y, Li M, Ouyang L, Ling J . Investigation of Synthetic Magnetic Resonance Imaging Applied in the Evaluation of the Tumor Grade of Bladder Cancer. J Magn Reson Imaging. 2021; 54(6):1989-1997. DOI: 10.1002/jmri.27770. View

12.

Amlicke M, Park J, Agala C, Casey D, Ray E, Downs-Canner S . Prevalence of Pathologic N2/N3 Disease in Postmenopausal Women with Clinical N0 ER+/HER2- Breast Cancer. Ann Surg Oncol. 2022; 29(12):7662-7669. PMC: 9561012. DOI: 10.1245/s10434-022-12056-4. View

13.

Warntjes J, Dahlqvist Leinhard O, West J, Lundberg P . Rapid magnetic resonance quantification on the brain: Optimization for clinical usage. Magn Reson Med. 2008; 60(2):320-9. DOI: 10.1002/mrm.21635. View

14.

Zhang-Yin J, Mauel E, Talpe S . Update on Sentinel Lymph Node Methods and Pathology in Breast Cancer. Diagnostics (Basel). 2024; 14(3). PMC: 10855371. DOI: 10.3390/diagnostics14030252. View

15.

Choi E, Youk J, Choi H, Song J . Dynamic contrast-enhanced and diffusion-weighted MRI of invasive breast cancer for the prediction of sentinel lymph node status. J Magn Reson Imaging. 2019; 51(2):615-626. DOI: 10.1002/jmri.26865. View

16.

Gracien R, Reitz S, Hof S, Fleischer V, Zimmermann H, Droby A . Changes and variability of proton density and T1 relaxation times in early multiple sclerosis: MRI markers of neuronal damage in the cerebral cortex. Eur Radiol. 2015; 26(8):2578-86. DOI: 10.1007/s00330-015-4072-x. View

17.

Zheng Y, Sun J, Zhu L, Hu M, Hou L, Liu J . Diagnosing sentinel lymph node metastasis of T1/T2 breast cancer with conventional ultrasound combined with double contrast-enhanced ultrasound: a preliminary study. Quant Imaging Med Surg. 2023; 13(6):3451-3463. PMC: 10239995. DOI: 10.21037/qims-22-1175. View

18.

Kurt N, Kurt B, Gulsaran U, Uslu B, Celik A, Sut N . Diffusion tensor imaging and diffusion-weighted imaging on axillary lymph node status in breast cancer patients. Diagn Interv Radiol. 2022; 28(4):329-336. PMC: 9634923. DOI: 10.5152/dir.2022.21460. View

19.

Cui Y, Han S, Liu M, Wu P, Zhang W, Zhang J . Diagnosis and Grading of Prostate Cancer by Relaxation Maps From Synthetic MRI. J Magn Reson Imaging. 2020; 52(2):552-564. DOI: 10.1002/jmri.27075. View

20.

Sogani J, Morris E, Kaplan J, DAlessio D, Goldman D, Moskowitz C . Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging. Radiology. 2016; 282(1):63-73. PMC: 5207122. DOI: 10.1148/radiol.2016160284. View